Hepcinat Plus (Sofosbuvir & Daklatasvir) is an effective innovative drug for the treatment of chronic hepatitis C, in people over 18 years old, which is used in combination with other drugs in complex antiviral therapy. After numerous clinical trials, positive dynamics is observed in most patients with a weakened disease and is, moreover, quite stable. You can order Sofosbuvir for hepatitis C in our pharmacy at the best price.
Hepcinat Plus (Sofosbuvir & Daklatasvir) is one of the latest modern German direct antiviral drugs that inhibit the NS5B polymerase of the hepatitis C virus. The therapeutic effect of the drug Sofosbuvir is achieved due to the active substance of the same name, which suppresses the multiplication of the hepatitis C virus.
Sofosbuvir is an antisense nucleotide that inhibits the RNA-dependent RNA polymerase NS5B; this drug has earned a reputation as one of the strongest anti-replicative agents, including for interferon resistance.
Daclatasvir is a highly specific agent of direct action against the hepatitis C virus and does not have pronounced activity against other RNA and DNA viruses, including HIV . Daclatasvir is an inhibitor of non-structural protein 5A (NS5A), a multifunctional protein required for replication of the hepatitis C virus, and thus inhibits two stages of the viral life cycle – viral RNA replication and virion assembly.